title: GRAPPA 2015 Research and Education Project Reports.
abstract: At the 2015 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), attendees were presented with brief updates on several ongoing initiatives, including educational projects. Updates were presented on the treatment recommendations project, the development of simple criteria to identify inflammatory musculoskeletal disease, new patient/physician Delphi exercises, and BIODAM (identifying biomarkers that predict progressive structural joint damage). The publication committee also gave a report. Herein we summarize those project updates.
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah. pmease@philipmease.com.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Mease
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Philip S
authors.initials: PS
authors.lastname: Helliwell
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Wolf-Henning
authors.initials: WH
authors.lastname: Boehncke
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Laura C
authors.initials: LC
authors.lastname: Coates
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Oliver
authors.initials: O
authors.lastname: FitzGerald
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Dafna D
authors.initials: DD
authors.lastname: Gladman
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Atul A
authors.initials: AA
authors.lastname: Deodhar
authors.affiliation: From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.
authors.forename: Kristina
authors.initials: K
authors.lastname: Callis Duffin
mesh_terms: D015535:Arthritis, Psoriatic; D003880:Dermatology / Q000193:education*; D006801:Humans; D011565:Psoriasis; D012106:Research; D012219:Rheumatology / Q000193:education*
keywords: ARTHRITIS ASSESSMENT; EDUCATION; PSORIASIS; PSORIATIC ARTHRITIS